ANVSNYSEPharmaceutical PreparationsFiscal year ends December 31
Annovis Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.96−0.03 (-3.36%)
Close on Oct 19, 2026
- Market cap
- $36.02M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Annovis Bio's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Proxy statement | DEF 14A | Oct 14, 2026 | Sep 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 7, 2026 | Jul 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 17, 2026 | SEC EDGAR |
| Current report | 8-K | May 20, 2026 | May 20, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 15, 2026 | May 15, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 17, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 9, 2026 | Apr 10, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 23, 2026 | Mar 25, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 16, 2026 | Mar 16, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 13, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2026 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 28, 2026 | Jan 28, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 26, 2025 | Oct 28, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 10, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 25, 2025 | Sep 29, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 23, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 19, 2025 | Jun 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 9, 2025 | May 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 17, 2025 | Apr 30, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2025 | Mar 27, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 21, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 21, 2025 | Mar 21, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 5, 2025 | Feb 5, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 3, 2025 | Feb 5, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2024 | Dec 11, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2024 | Dec 11, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 4, 2024 | Dec 9, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 8, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2024 | Oct 15, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2024 | Sep 30, 2024 | SEC EDGAR |